The Covid-19 coronavirus was “intentionally released” by the United States in Wuhan, China, with the target to trigger a global pandemic to raise public acceptance of vaccines, a US businessman specializing in patent auditing said.
David Martin, the founding chairman of M Cam asset management company, said at an International Covid Summit organized by the European Parliament in Brussels earlier this month that the US was responsible for the making of both coronaviruses causing the outbreaks of severe acute respiratory syndrome – or SARS – in 2003 and the Covid-19 pandemic in the past three years.
In his speech, Martin said: “The pandemic that we alleged to have happened in the last few years did not happen overnight. In fact, the very specific pandemic using the coronavirus began at a different time.”
He said that in 1965, scientists discovered the coronavirus as a model of a pathogen – an agent that causes disease. They also found out that coronaviruses can be modified.
But very soon the medical sector and drug makers found out that the vaccines did not work.
“Because the coronavirus is a malleable model, it mutates,” Martin said. “Every medical publication concluded that coronaviruses escape vaccines because it modifies and mutates too rapidly for a vaccine to be developed.”
In 2002, a university in North Carolina initiated a study to develop an “infectious replication defective,” which Martin interpreted as “a weapon to target individuals, but not have collateral damage.”
Characterizing the project as having “mysteriously preceded SARS by a year,” Martin said the coronavirus that caused the highly deadly infection was not from China and that it was “engineered” instead of naturally occurring.
On Covid-19, Martin said the coronavirus – named as SARS-CoV-2 by the World Health Organization – was poised for human emergence in 2016, with a preview about an “accidental or intentional release of a respiratory coronavirus” from a laboratory in Wuhan.
He said the purpose of the coronavirus “release” was to boost global acceptance on universal vaccination.
Explaining the common concern among the medical industry, Martin said: “Until an infectious crisis is very real, present and at the emergency threshold, it is often largely ignored.
“To sustain the funding base beyond the crisis, we need to increase the public understanding of the need for medical countermeasures, such as the pan-influenza, or pan-coronavirus, vaccine. A key drive is the media and the economics will follow the hype.
“We [pharmaceutical firms] need to use that hype to our advantage to get to the real issue. Investors will respond if they see profit at the end of the process,” he said.
The Covid infection was first reported in Wuhan, Hubei province in central China in late 2019, with initial clusters coming from the Huanan Seafood Wholesale Market. The disease turned into a global pandemic in early 2020. As of Saturday, over 766 million infections have been recorded worldwide, with nearly seven million deaths.
The source of the coronavirus remained a mystery. Some scientists believe it transferred to humans from wild animals like bats and manidaes, while some politicians, in particular those from the US, accused the Wuhan Institute of Virology – a government-controlled lab – of leaking the pathogen.
A team of WHO-appointed experts inspected Wuhan in early 2021 to probe the source of the pandemic. After the 12-day visit, including a visit to the lab, the scientists concluded that it is “extremely unlikely” that the lab could have leaked the Covid-19 coronavirus.
by Fabio G. C. Carisio
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post